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Starting from the readily available 2-alkyl-4-formylimidazole
substituted-pyrrolo[2,3-d] im idazoles and su bstituted-pyr-
rolo[3,2-d]imidazoles have been prepared.
In view of antihypertensive activity of2-alkyl-N-
benzyl fused imidazoles", it was of our interest to
prepare the title compounds as possible effective
drugs against hypertension. The syntheses of the









a) R = propyl b) R = butyl
Scheme I
Note
Alkylation/ of 2-alkyl-4-formylimidazoles 13
with 4- carbomethoxylbenzyl bromide 2 gave a 70:30
mixture of 2-alkyl-l- (4-carbomethoxybenzyl)-4-
formyl imidazole 3 and 2-alkyl-l-( 4- carbornethoxy-
benzyl)-S-formylimidazole 4 respectively. These
compounds were separated by column chromatogra-
phy on silica gel. The structures of isomers were
established by IH-NMR. Benzylic protons of com-
pound 4 were more deshielded than that of compound
3, which appeared at S.63 and S.17 ppm respectively.
In addition NMR spectral data of compound 4 was
similar to previously reported one4.
Condensation of compounds 3 and 4 with ethyl
azidoacetate under the condition reported pre-
viously' afforded ethyl a- azido-(3-[2-alkyl-l-( 4-car-
bethoxybenzyl) imidzol-4- ylJacrylate 5 and
a-azido-(3-[2-alkyl-l-( 4-carbethoxybenzyl) imida-
zol-S-ylJacrylate 6.
The NMR spectra of compounds 5 and 6 were in
agreement with the suggested structures. The (3-
vinylic proton appeared at 6.60-7.1 0 ppm. This.value
is similar to the one reported previously".
CyC\ization of compounds 5 and 6 to the desired
compounds 7 and 8 was accomplished through heat-
ing the former in xylene. The structures of com-
pounds 7 and 8 were confirmed by spectroscopic
methods (IR, NMR and MS) and chemical analysis.
The physical constant of compounds 7 and 8 are
summarized in Table I.
Experimental Section
Melting points were determined on a Kofler hot
stage apparatus and are uncorrected. IR were ob-
tained in KBr using a Perkin-Elmer Model 267 spec-
trograph Cmax in ern"), IH-NMR spectra in CDCb
on a Bruker AC-80 spectrometer using TMS as an
internal standard (chemical shifts in 0, ppm) and mass
spectra on a Finnigan MAT TSQ 70 spectrometer at
70 eV. Column chromatography was carried out
using silica gel (230-400 mesh). Elemental analyses
were carried out by the research centre of petro-
chemical company.
2-Butyl-l-(4-carbomethoxybenzyl) - 4 -formylim-
idazole 3b. A stirring suspension of compound Ib
(7g, 46 mmoles), anhyd. sodium carbonate (4.88 g,
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Table I-Physical constants of compounds 7a, 7b, 8a and 8b.
% round (Calcd)
Compd. rn.p." Yield Mol. formula C H N
(C) (%)
7a 160 27 C21H2SN304 65.76(65.80) 6.48(6.53) 10.71(10.97)
7b 159-61 28 C22H27N304 66.72(66.50) 6.61(6.80) I0.43( I0.58)
8a 155 21 C21H2SN304 65.91(65.80) 6.43(6.53) 10.86(i0.97)
8b 105-8 22 C22H27N304 66.25(66.50) 6.71(6.80) 10.47(10.58)
* All compounds were crystallized from carbon tetrachloride
46 mmoles), and compound 2 (11 g, 48 mmoles) in
DMF (100 mL) was heated at 100° for 24 hr. After
cooling the mixture was filtered. The filtrate was
evaporated at reduced pressure. The oily residue was
purified by column chromatography on silica gel
eluting with ethyl acetate to give 7.4 g of oily com-
pound 3b, yield 54%; IR: 1720 (C=O ester), 1680
cm-1(C=O aldehyde); NMR (CDC!): 9.44 (s, IH,
CHO), 8.00 (d, 2H, J=8.5 Hz, Ar), 7.53 (s, IH, H-5
imidazole), 7.14 (d, 2H, J=8.5 Hz, Ar), 5.17 (s, 2H,
CH2 benzylic), 3.92 (s, 3H, C02CH3), 2.64 (t, 2H,
J=7.7 Hz, CH2), 1.46 (m, 4H, CH2), 0.87 (s, 3H,
J=7.3, CH3); MS: rn/z (%) 301 (M++ 1,21),258 (62),
243 (8), 167 (16), 149 (100), 121 (41).
2-Butyl-l-(4-carbomethoxybenzyl) - 5 -formylim-
idazole 4b. It was prepared similar to 3b in 27%
yield. Ethyl acetate-pet. ether (1: 1)was used as eluent
in chromatography. IR: 1720 (C=O ester), 1675 ern"
I(C=O aldehyde);NMR(CDC!): 9.67 (s, IH, CHO),
7.98 (d, 2H, J=8.4 Hz, Ar), 7.81 (s, IH, H4 imida-
zole), 7.06 (d, 2H, J=8.3 Hz, Ar), 5.63 (s, 2H, CH2
benzylic), 3.90 (s, 3H, C02CH3), 2.63 (t, 2H, J=7.7
Hz, CH2), 1.46 (m, 4H, CH2), 0.87 (t, 3H, J=7.3 Hz,
CH3); MS: m/z (%) 301 (M++l, 100),271 (11),258
(24), 229 (24), 149, (24), 121 (29).
a-Azido-j3-[2-butyl-l-( 4- carbethoxybenzyl)imi-
dazol-4-yIJacrylate 5b. To a stirring solution of
sodium (0.8 g, 34.68 mmoles) in abs. ethanol (25 mL)
at 20° was added dropwise a solution of 3b (2.6 g,
8.67 mmoles) and ethyl azidoacetate (4.4 g, 34.68
mmoles) in dry THF (50 mL) and abs. ethanol (80
mL). After 2 hr at _10°, the mixture was added to a
saturated solution of ammonium chloride. The mix-
ture was extracted with ether. The organic layer was
evaporated at reduced pressure and the residue was
purified with column chromatography, eluting with
chloroform to give 1.45 g of an oily compound, yield
40%; IR: 2119 (azide), 1712 ern" (C=O); NMR
(CDC!): 7.98 (d, 2H,J= 8.0 Hz, Ar), 7.65 (s, IH H-5,
imidazole), 7.10 (d, 2H,J=8.0 Hz, Ar), 7.06 (s, IH,
CH=C), 5.15 (s, 2H, CH2 benzylic), 4.33 (q, 4H,
C02CH2), 2.50 (t, 2H,J=8.0 Hz, CH2), 1.38 (m, 10H,
CH2, CH3), 0.87 (t, 3H, CH3); MS: m/z (%) 425(M+,
1),399(14),355(5),313(28),236(9),192(57),163
(100), 135 (43), 107 (88).
a-Azido-j3-[2-butyl-l-( 4- carbethoxybenzyl)imi-
dazol-5-yIJacrylate 6b. It was prepared similar to
5b in 66% yield; IR: 2126 (azide), 1719 cm-1 (C=O);
NMR (CDC!): 8.00 (d, 2H, J=8.0 Hz, Ar), 7.90 (s,
IH, H4 imidazole), 7.00 (d 2H, J=8.0 Hz, Ar), 6.50
(s, IH, CH=C), 5.19 (s, 2H,CH2 benzylic), 4.32 (m,
4H, C02CH2),2.65 (t, 2H, J=8.0 Hz, CH2), 1.46 (m,




rolo[3,2-d]imidazole-5- carboxylate 7b. A solu-
tion of5b (6 g, 14 mmoles) in xylene (100 mL) was
refluxed for 2 hr. The solvent was evaporated and
the residue was purified by column chromatography
eluting with chloroform-pet. ether (I: I) to give 1.53
g of7b, m.p. 160° (carbon tetrachloride), yield 28%;
IR: 1718 ern" (C=O); NMR (CDC!): 9.20 (bs, IH,
NH), 8.00(d, 2H, J=8.2 Hz, Ar), 7.20 (d, 2H, J=8.2
Hz, Ar), 6.92 (5, IH, H-C4), 5.28 (5, 2H, CH2 ben-
zylic), 4.35 (m, 4H, C02CH2), 2.70 (t, 2H, CH2), 1.38
(m, 10H, CH2, CH3), 0.89 (t, 3H, CH3); MS: rn/z (%)
397 (W, 4),192 (100), 135 (28),107 (50).
Ethyl 2-propyl-l-( 4-carbethoxybenzyl)-pyr-
rolo[3,2-dJimidazole-5- carboxylate 7a. It was pre-
pared from 5a by the procedure described for 7b. IR:
1718 cm-1(C=O); NMR (CDC!): 8.90 (bs, 1fl, NH),
8.03 (d, 2H, J=8.3 Hz, Ar), 7.02 (d, 2H, J=8.3 Hz,
Ar), 6.92 (5, IH, H-C4), 5.27 (5, 2H, CH2 benzylic),
4.28 (m, 4H, C02CH2), 2.70 (t, 2H, CH2), 1.80 (m,
2H, CH2),1.38 (m, 6H, CH3); 0.99 (t, 3H, CH3); MS:
mlz(%) 383 (M+, 13), 192(54), 163(100), 101 (63).
Ethyl 2-bu tyl-l-( 4-carbethoxybenzyl)-pyr-
rolo[2,3-d)imidazole-5- carboxylate 8b. It was pre-
pared similar to 7b in 22% yield; m.p. 105-8°; IR:
1728 cm-1(C=O); NMR(CDCb): 9.70 (bs, IH, NH),
8.00 (d, 2H,J=8.4 Hz, Ar), 7.20 (d, 2H,J=8.4Hz, Ar),
6.40 (s, IH, H-C6), 5.22 (s, 2H, CH2 benzylic), 4.32
(q, 4H, C02CH2), 2.83 (t, 2H, CH2), 1.38 (m, 10~,
CH2, CH3), 0.91 (t, 3H, CH3); MS: m/z (%) 397 (M ,
1),192 (100),163 (74),107 (50), 90 (38).
Ethyl 2-propyl-l-( 4-carbethoxybenzyl)-pyr-
rolo[2,3-d)imidazole-5- carboxylate 8a. It was pre-
pared from 6a by the procedure described for 8b. IR:
1728 cm-1(C=O); NMR (CDCb): 9.50 (bs, 1H, NH),
8.00 (d, 2H, J=8.3 Hz, Ar), 7.19 (d, 2H, J=8.3 Hz,
Ar) 6.4 (s, IH, H-C6), 5.22 (s, 2H, CH2 benzylic),
4.32 (q, 4H, C02CH2), 2.80 (t, 2H, CH2), 1.80 (m,
NOTES 815
2H, CH2), 1.38 (m, 6H, CH3), 0.99 (t, 3H, CH3); MS:
mlz(%) 383 (W, 27), 309 (12),192 (59),163 (100),
107 (68).
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